ES2181763T3 - Formulaciones a base de fenbendazol. - Google Patents

Formulaciones a base de fenbendazol.

Info

Publication number
ES2181763T3
ES2181763T3 ES95901776T ES95901776T ES2181763T3 ES 2181763 T3 ES2181763 T3 ES 2181763T3 ES 95901776 T ES95901776 T ES 95901776T ES 95901776 T ES95901776 T ES 95901776T ES 2181763 T3 ES2181763 T3 ES 2181763T3
Authority
ES
Spain
Prior art keywords
fenbendazol
formulations based
fenbendazole
standing
efficacious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95901776T
Other languages
English (en)
Inventor
Leslie E Kyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2181763T3 publication Critical patent/ES2181763T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Lock And Its Accessories (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)

Abstract

ESTA SOLICITUD SE REFIERE A UNA FORMULACION ACUOSA DE FENBENDAZOL QUE ES ESTABLE Y EFICAZ, NO SE AGLOMERA AL ESTAR DE PIE Y EN DONDE EL FENBENDAZOL PERMANECE EN SUSPENSION AL ESTAR DE PIE DURANTE VEINTICUATRO HORAS.
ES95901776T 1993-11-10 1994-11-09 Formulaciones a base de fenbendazol. Expired - Lifetime ES2181763T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/149,877 US5538989A (en) 1993-11-10 1993-11-10 Fenbendazole formulations

Publications (1)

Publication Number Publication Date
ES2181763T3 true ES2181763T3 (es) 2003-03-01

Family

ID=22532170

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95901776T Expired - Lifetime ES2181763T3 (es) 1993-11-10 1994-11-09 Formulaciones a base de fenbendazol.

Country Status (14)

Country Link
US (1) US5538989A (es)
EP (1) EP0727996B1 (es)
JP (1) JP3523260B2 (es)
KR (1) KR960705563A (es)
AT (1) ATE221780T1 (es)
BR (1) BR9408023A (es)
CA (1) CA2176223C (es)
DE (1) DE69431162T2 (es)
DK (1) DK0727996T3 (es)
ES (1) ES2181763T3 (es)
MY (1) MY115429A (es)
PH (1) PH31320A (es)
PT (1) PT727996E (es)
WO (1) WO1995013065A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES950907A2 (en) * 1995-12-01 1996-02-21 Chanelle Chemicals Ltd "A process"
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
PT1214052E (pt) * 1999-09-03 2004-12-31 Janssen Pharmaceutica Nv Formulacao veterinaria para a administracao de um medicamento insoluvel em agua a um animal visado, atraves de um sistema de distribuicao de agua
GB0105358D0 (en) * 2001-03-03 2001-04-18 Fluid Technologies Ltd Absorbent materials
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2005099692A1 (en) * 2004-04-07 2005-10-27 Intervet International B.V Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
WO2007144362A1 (en) 2006-06-14 2007-12-21 Intervet International B.V. A suspension comprising benzimidazole carbamate and a polysorbate
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
CN103025318B (zh) * 2010-08-24 2016-07-06 大塚制药株式会社 含有喹啉酮衍生物、和硅油和/或硅油衍生物的悬浮液和块状组合物
CA3033065A1 (en) * 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
CN106727304B (zh) * 2017-04-06 2019-09-03 江西博莱大药厂有限公司 一种芬苯达唑混悬剂及其制备方法
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
WO2024026463A1 (en) * 2022-07-28 2024-02-01 Happy Healing Inc. Composition for nasal delivery of an active compound
CN116602964B (zh) * 2023-07-18 2023-09-22 山东国邦药业有限公司 一种芬苯达唑粉及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE684059A (es) * 1965-07-15 1967-01-13
BE793358A (fr) * 1971-12-27 1973-06-27 Hoechst Ag Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation
US3897559A (en) * 1972-07-06 1975-07-29 Lilly Co Eli Anthelmintic phenylhydrazones
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US4197307A (en) * 1977-04-12 1980-04-08 Ciba-Geigy Corporation 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
DE3373276D1 (en) * 1982-03-30 1987-10-08 Hoechst Uk Ltd Anthelmintic preparations

Also Published As

Publication number Publication date
WO1995013065A1 (en) 1995-05-18
JP3523260B2 (ja) 2004-04-26
DK0727996T3 (da) 2002-11-18
JPH09506086A (ja) 1997-06-17
EP0727996A4 (en) 1996-11-06
MY115429A (en) 2003-06-30
BR9408023A (pt) 1996-12-10
EP0727996A1 (en) 1996-08-28
DE69431162D1 (en) 2002-09-12
EP0727996B1 (en) 2002-08-07
DE69431162T2 (de) 2002-12-12
US5538989A (en) 1996-07-23
CA2176223C (en) 2003-02-11
ATE221780T1 (de) 2002-08-15
CA2176223A1 (en) 1995-05-18
PH31320A (en) 1998-07-06
KR960705563A (ko) 1996-11-08
PT727996E (pt) 2002-11-29

Similar Documents

Publication Publication Date Title
DK0781551T3 (da) Retinoid-formuleringer i porøse mikrosfærer til nedsat irritation og forbedret stabilitet
ES2181763T3 (es) Formulaciones a base de fenbendazol.
YU47204B (sh) Derivati didehidro-vitamina d3
DK0732935T3 (da) Lyofiliserede stamcellefaktorformuleringer
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
FI962445A7 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
PL285248A1 (en) Method of obtaining novel aminophenol derivatives
DK0711140T3 (da) Antimykotisk opløsning til negle
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
ES2026754A6 (es) Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
AU4714297A (en) Metalloproteinase inhibitors
EP0134483A3 (en) Skin care composition
DK0391185T3 (da) 1,8-Naphthyridiner
BG100248A (bg) Инхибитори на скваленсинтетаза
FI910112A0 (fi) Preparat foer lokalt bruk.
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
TW345602B (en) Storage-stable liquid brightener formulations
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
SV1990000045A (es) Preparacion de cicloalcano [b] dehidroindol e-inosulfonamidas sustituidas, ref. le a 27 157-sv.